Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Juliana Lopes Rangel Fietto is active.

Publication


Featured researches published by Juliana Lopes Rangel Fietto.


Hydrometallurgy | 2000

Bioleaching of zinc and nickel from silicates using Aspergillus niger cultures

Ieso de Miranda Castro; Juliana Lopes Rangel Fietto; Reinaldo Xisto Vieira; Maria José Magalhães Trópia; Lígia Maria Moreira de Campos; Eucler B. Paniago; Rogélio Lopes Brandão

In this work, we investigated the role of bacteria from the genera Bacillus and Pseudomonas and fungi from the genera Aspergillus and Penicillium in the leaching process of two different silicates (calamine and garnierite). Since the results obtained with A. niger were better than those with different bacteria, a more detailed investigation of the leaching process with this microorganism was conducted. Moreover, although it is clear that the citric acid generated by fungi could be an important leaching agent acting in the solubilization of the used silicates, other products of metabolism could be involved. Related to this, the results obtained with chemical leaching using low concentrations of citric acid (lower than 10 mM) showed, for both calamine and garnierite, that the respective dissolution of zinc and nickel was much lower when compared to those processes in which cultures or supernatant liquor of A. niger cultures were used and in which the maximum concentration of citric acid was 8 mM. The results obtained also suggest that the type of mineral (and/or the metal present in it) presents a different susceptibility to the bioleaching process and also demonstrate that depending of the situation, the presence of the fungi cells seem to improve the leaching process. From a practical point of view, the high yield rate of extracting metals from silicates obtained by using for example, supernatant liquors of A. niger cultures, is noteworthy. This bioleaching process present two advantages as compared to conventional chemical leaching processes: (a) the very low concentrations of organic compounds present in such a situation represent a lower ecological risk; and (b) even with a lower final yield, the economical cost of a such process. Both characteristics could facilitate its industrial application.


Parasitology Research | 2004

Immune response induced by New World Leishmania species in C57BL/6 mice

Tatiani Uceli Maioli; Erica Takane; Rosa Maria Esteves Arantes; Juliana Lopes Rangel Fietto; Luís Carlos Crocco Afonso

Abstract In the present study, C57BL/6 mice were inoculated with metacyclic Leishmania amazonensis or L. braziliensis promastigotes. While these animals were capable of controlling the infection by L. braziliensis, they developed chronic lesions with elevated numbers of parasites when infected by L. amazonensis. The differences in parasite control were associated with a decreased production of IFN-γ and TNF by lymph node cells from L. amazonensis-infected mice. Furthermore, these animals presented decreased spleen cell proliferation and activation of germinal centers. In addition, we compared the ability of these parasites to hydrolyze extracellular ATP and AMP. While the ATPase activity of both parasite species was similar, L. amazonensis promastigotes presented higher AMP hydrolytic activity. This increased activity may lead to an increased production of adenosine, which has been shown to present anti-inflammatory activity and may thus be involved in the establishment of the immunosuppression observed in mice infected by L. amazonensis.


PLOS Neglected Tropical Diseases | 2009

Influence of ecto-nucleoside triphosphate diphosphohydrolase activity on Trypanosoma cruzi infectivity and virulence.

Ramon F. Santos; Marcela A. S. Pôssa; Matheus S. Bastos; Paulo Marcos da Matta Guedes; Márcia Rogéria de Almeida; Ricardo DeMarco; Sergio Verjovski-Almeida; Maria Terezinha Bahia; Juliana Lopes Rangel Fietto

Background The protozoan Trypanosoma cruzi is the causative agent of Chagas disease. There are no vaccines or effective treatment, especially in the chronic phase when most patients are diagnosed. There is a clear necessity to develop new drugs and strategies for the control and treatment of Chagas disease. Recent papers have suggested the ecto-nucleotidases (from CD39 family) from pathogenic agents as important virulence factors. In this study we evaluated the influence of Ecto-Nucleoside-Triphosphate-Diphosphohydrolase (Ecto-NTPDase) activity on infectivity and virulence of T. cruzi using both in vivo and in vitro models. Methodology/Principal Findings We followed Ecto-NTPDase activities of Y strain infective forms (trypomastigotes) obtained during sequential sub-cultivation in mammalian cells. ATPase/ADPase activity ratios of cell-derived trypomastigotes decreased 3- to 6-fold and infectivity was substantially reduced during sequential sub-cultivation. Surprisingly, at third to fourth passages most of the cell-derived trypomastigotes could not penetrate mammalian cells and had differentiated into amastigote-like parasites that exhibited 3- to 4-fold lower levels of Ecto-NTPDase activities. To evidence the participation of T. cruzi Ecto-NTPDase1 in the infective process, we evaluated the effect of known Ecto-ATPDase inhibitors (ARL 67156, Gadolinium and Suramin), or anti-NTPDase-1 polyclonal antiserum on ATPase and ADPase hydrolytic activities in recombinant T. cruzi NTPDase-1 and in live trypomastigotes. All tests showed a partial inhibition of Ecto-ATPDase activities and a marked inhibition of trypomastigotes infectivity. Mice infections with Ecto-NTPDase-inhibited trypomastigotes produced lower levels of parasitemia and higher host survival than with non-inhibited control parasites. Conclusions/Significance Our results suggest that Ecto-ATPDases act as facilitators of infection and virulence in vitro and in vivo and emerge as target candidates in chemotherapy of Chagas disease.


Virus Research | 2012

Tripping over emerging pathogens around the world: A phylogeographical approach for determining the epidemiology of Porcine circovirus-2 (PCV-2), considering global trading

Pedro Marcus Pereira Vidigal; Cláudio Mafra; F.F. Silva; Juliana Lopes Rangel Fietto; Abelardo Silva Júnior; Márcia Rogéria de Almeida

Porcine circovirus-2 (PCV-2) is an emerging virus associated with a number of different syndromes in pigs known as Porcine Circovirus Associated Diseases (PCVAD). Since its identification and characterization in the early 1990s, PCV-2 has achieved a worldwide distribution, becoming endemic in most pig-producing countries, and is currently considered as the main cause of losses on pig farms. In this study, we analyzed the main routes of the spread of PCV-2 between pig-producing countries using phylogenetic and phylogeographical approaches. A search for PCV-2 genome sequences in GenBank was performed, and the 420 PCV-2 sequences obtained were grouped into haplotypes (group of sequences that showed 100% identity), based on the infinite sites model of genome evolution. A phylogenetic hypothesis was inferred by Bayesian Inference for the classification of viral strains and a haplotype network was constructed by Median Joining to predict the geographical distribution of and genealogical relationships between haplotypes. In order to establish an epidemiological and economic context in these analyses, we considered all information about PCV-2 sequences available in GenBank, including papers published on viral isolation, and live pig trading statistics available on the UN Comtrade database (http://comtrade.un.org/). In these analyses, we identified a strong correlation between the means of PCV-2 dispersal predicted by the haplotype network and the statistics on the international trading of live pigs. This correlation provides a new perspective on the epidemiology of PCV-2, highlighting the importance of the movement of animals around the world in the emergence of new pathogens, and showing the need for effective sanitary barriers when trading live animals.


PLOS Neglected Tropical Diseases | 2012

Ecto-nucleotidase activities of promastigotes from leishmania (Viannia) braziliensis relates to parasite infectivity and disease clinical outcome.

Pauline M. Leite; Rodrigo Saar Gomes; Amanda Braga Figueiredo; Tiago Donatelli Serafim; Wagner Luiz Tafuri; Carolina Carvalho de Souza; Sandra Aparecida de Lima Moura; Juliana Lopes Rangel Fietto; Maria Norma Melo; Fátima Ribeiro-Dias; Milton Adriano Pelli de Oliveira; Ana Rabello; Luís Carlos Crocco Afonso

Background Leishmania (Viannia) braziliensis has been associated with a broad range of clinical manifestations ranging from a simple cutaneous ulcer to destructive mucosal lesions. Factors leading to this diversity of clinical presentations are not clear, but parasite factors have lately been recognized as important in determining disease progression. Given the fact that the activity of ecto-nucleotidases correlates with parasitism and the development of infection, we evaluated the activity of these enzymes in promastigotes from 23 L. braziliensis isolates as a possible parasite-related factor that could influence the clinical outcome of the disease. Methodology/Principal Findings Our results show that the isolates differ in their ability to hydrolyze adenine nucleotides. Furthermore, we observed a positive correlation between the time for peak of lesion development in C57BL/6J mice and enzymatic activity and clinical manifestation of the isolate. In addition, we found that L. (V.) braziliensis isolates obtained from mucosal lesions hydrolyze higher amounts of adenine nucleotides than isolates obtained from skin lesions. One isolate with high (PPS6m) and another with low (SSF) ecto-nucleotidase activity were chosen for further studies. Mice inoculated with PPS6m show delayed lesion development and present larger parasite loads than animals inoculated with the SSF isolate. In addition, PPS6m modulates the host immune response by inhibiting dendritic cell activation and NO production by activated J774 macrophages. Finally, we observed that the amastigote forms from PPS6m and SSF isolates present low enzymatic activity that does not interfere with NO production and parasite survival in macrophages. Conclusions/Significance Our data suggest that ecto-nucleotidases present on the promastigote forms of the parasite may interfere with the establishment of the immune response with consequent impaired ability to control parasite dissemination and this may be an important factor in determining the clinical outcome of leishmaniasis.


Antimicrobial Agents and Chemotherapy | 2015

Concomitant Benznidazole and Suramin Chemotherapy in Mice Infected with a Virulent Strain of Trypanosoma cruzi

Eliziária C. Santos; Rômulo Dias Novaes; Marli C. Cupertino; Daniel S. S. Bastos; Raphael Contelli Klein; Eduardo de Almeida Marques da Silva; Juliana Lopes Rangel Fietto; André Talvani; Maria Terezinha Bahia; Leandro Licursi de Oliveira

ABSTRACT Although suramin (Sur) is suggested as a potential drug candidate in the management of Chagas disease, this issue has not been objectively tested. In this study, we examined the applicability of concomitant treatment with benznidazole (Bz) and suramin in mice infected with a virulent strain of Trypanosoma cruzi. Eighty 12-week-old male C57BL/6 mice were equally randomized in eight groups: (i) noninfected mice (negative control) and mice infected with T. cruzi Y strain receiving (ii) no treatment (positive control), (iii) Bz, 100 mg/kg of body weight per day, (iv) Sur, 20 mg/kg/day, and (v to viii) Sur, 20 mg/kg/day, combined with Bz, 100, 50, 25, or 5 mg/kg/day. Bz was administered by gavage, and Sur was administered intraperitoneally. Sur dramatically increased the parasitemia, cardiac content of parasite DNA, inflammation, oxidative tissue damage, and mortality. In response to high parasitic load in cardiac tissue, Sur stimulated the immune system in a manner typical of the acute phase of Chagas disease, increasing tissue levels of gamma interferon (IFN-γ) and tumor necrosis factor alpha (TNF-α) and inducing a preferential IgG2a anti-T. cruzi serum pattern. When Sur and Bz were combined, the infection severity was attenuated, showing a dose-dependent Bz response. Sur therapy had a more harmful effect on the host than on the parasite and reduced the efficacy of Bz against T. cruzi infection. Considering that Sur drastically reinforced the infection evolution, potentiating the inflammatory process and the severity of cardiac lesions, the in vivo findings contradicted the in vitro anti-T. cruzi potential described for this drug.


BioMed Research International | 2015

Splicing Regulators and Their Roles in Cancer Biology and Therapy.

Maria Roméria da Silva; Gabriela Alves Moreira; Ronni Anderson Gonçalves da Silva; Éverton de Almeida Alves Barbosa; Raoni Pais Siqueira; Róbson Ricardo Teixera; Márcia Rogéria de Almeida; Abelardo Silva Júnior; Juliana Lopes Rangel Fietto; Gustavo Costa Bressan

Alternative splicing allows cells to expand the encoding potential of their genomes. In this elegant mechanism, a single gene can yield protein isoforms with even antagonistic functions depending on the cellular physiological context. Alterations in splicing regulatory factors activity in cancer cells, however, can generate an abnormal protein expression pattern that promotes growth, survival, and other processes, which are relevant to tumor biology. In this review, we discuss dysregulated alternative splicing events and regulatory factors that impact pathways related to cancer. The SR proteins and their regulatory kinases SRPKs and CLKs have been frequently found altered in tumors and are examined in more detail. Finally, perspectives that support splicing machinery as target for the development of novel anticancer therapies are discussed.


Infection, Genetics and Evolution | 2013

Tracking the molecular epidemiology of Brazilian Infectious bursal disease virus (IBDV) isolates.

F.F. Silva; Pedro Marcus Pereira Vidigal; Luciana Wanderley Myrrha; Juliana Lopes Rangel Fietto; Abelardo Silva; Márcia Rogéria de Almeida

Infectious bursal disease is a highly contagious disease of young chickens caused by Infectious bursal disease virus (IBDV). Genome segment A encodes the capsid protein (VP2), while segment B encodes the RNA-dependent RNA polymerase (VP1). In the present study, we trace the molecular epidemiology of IBDV in Brazil by analyzing 29 isolates collected in the major regions of poultry production. To genetically characterize the isolates, phylogenetic and population dynamic analyses were conducted using 68 VP1 (2634 nt) and 102 VP2 (1356 nt) coding sequences from IBDV isolates from different regions of the world. Furthermore, the evolution of IBDV was analyzed by characterizing the selective forces that operated during the diversification of viral isolates. We show that IBDV isolates were introduced into Brazil mainly from the Netherlands and the USA. These introductions were associated with all Brazilian poultry production regions analyzed in this work. In addition, we show that the evolution of IBDV has been shaped by a combination of very low recombination rates and relatively high rates of nucleotide substitution (2.988×10(-4) for VP1 and 3.2937×10(-4) for VP2), which themselves are a function of purifying selection operating on VP1 and VP2. Furthermore, our extended Bayesian skyline plot suggests that the increase in the effective population size of isolates of IBDV is consistent with its epidemiological history, with a large increase during the emergence of acute outbreaks of IBD in the 1980s.


Journal of Automated Methods & Management in Chemistry | 2016

Immobilization of NTPDase-1 from Trypanosoma cruzi and Development of an Online Label-Free Assay

Felipe Antunes Calil; Juliana Maria Lima; Arthur Henrique Cavalcante de Oliveira; Christiane Mariotini-Moura; Juliana Lopes Rangel Fietto; Carmen Lúcia Cardoso

The use of IMERs (Immobilized Enzyme Reactors) as a stationary phase coupled to high performance chromatographic systems is an interesting approach in the screening of new ligands. In addition, IMERs offer many advantages over techniques that employ enzymes in solution. The enzyme nucleoside triphosphate diphosphohydrolase (NTPDase-1) from Trypanosoma cruzi acts as a pathogen infection facilitator, so it is a good target in the search for inhibitors. In this paper, immobilization of NTPDase-1 afforded ICERs (Immobilized Capillary Enzyme Reactors). A liquid chromatography method was developed and validated to monitor the ICER activity. The conditions for the application of these bioreactors were investigated, and excellent results were obtained. The enzyme was successfully immobilized, as attested by the catalytic activity detected in the TcNTPDase-1-ICER chromatographic system. Kinetic studies on the substrate ATP gave K M of 0.317 ± 0.044 mmol·L−1, which still presented high affinity compared to in solution. Besides that, the ICER was stable for 32 days, enough time to investigate samples of possible inhibitors, including especially the compound Suramin, that inhibited 51% the enzyme activity at 100 µmol·L−1, which is in accordance with the data for the enzyme in solution.


Molecules | 2015

The Antileishmanial Potential of C-3 Functionalized Isobenzofuranones against Leishmania (Leishmania) Infantum Chagasi

Wagner Luiz Pereira; Raphael de Souza Vasconcellos; Christiane Mariotini-Moura; Rodrigo Saar Gomes; Rafaela de Cássia Firmino; Adalberto Manoel da Silva; Abelardo Silva Júnior; Gustavo Costa Bressan; Márcia Rogéria de Almeida; Luís Carlos Crocco Afonso; Róbson Ricardo Teixeira; Juliana Lopes Rangel Fietto

Leishmaniases are diseases caused by protozoan parasites of the genus Leishmania. Clinically, leishmaniases range from cutaneous to visceral forms, with estimated global incidences of 1.2 and 0.4 million cases per year, respectively. The treatment of these diseases relies on multiple parenteral injections with pentavalent antimonials or amphotericin B. However, these pharmaceuticals are either too toxic or expensive for routine use in developing countries. These facts call for safer, cheaper, and more effective new antileishmanial drugs. In this investigation, we describe the results of the assessment of the activities of a series of isobenzofuran-1(3H)-ones (phtalides) against Leishmania (Leishmania) infantum chagasi, which is the main causative agent of visceral leishmaniasis in the New World. The compounds were tested at concentrations of 100, 75, 50, 25 and 6.25 µM over 24, 48, and 72 h. After 48 h of treatment at the 100 µM concentration, compounds 7 and 8 decreased parasite viability to 4% and 6%, respectively. The concentration that gives half-maximal responses (LC50) for the antileishmanial activities of compounds 7 and 8 against promastigotes after 24 h were 60.48 and 65.93 µM, respectively. Additionally, compounds 7 and 8 significantly reduced parasite infection in macrophages.Leishmaniases are diseases caused by protozoan parasites of the genus Leishmania. Clinically, leishmaniases range from cutaneous to visceral forms, with estimated global incidences of 1.2 and 0.4 million cases per year, respectively. The treatment of these diseases relies on multiple parenteral injections with pentavalent antimonials or amphotericin B. However, these pharmaceuticals are either too toxic or expensive for routine use in developing countries. These facts call for safer, cheaper, and more effective new antileishmanial drugs. In this investigation, we describe the results of the assessment of the activities of a series of isobenzofuran-1(3H)-ones (phtalides) against Leishmania (Leishmania) infantum chagasi, which is the main causative agent of visceral leishmaniasis in the New World. The compounds were tested at concentrations of 100, 75, 50, 25 and 6.25 µM over 24, 48, and 72 h. After 48 h of treatment at the 100 µM concentration, compounds 7 and 8 decreased parasite viability to 4% and 6%, respectively. The concentration that gives half-maximal responses (LC50) for the antileishmanial activities of compounds 7 and 8 against promastigotes after 24 h were 60.48 and 65.93 µM, respectively. Additionally, compounds 7 and 8 significantly reduced parasite infection in macrophages.

Collaboration


Dive into the Juliana Lopes Rangel Fietto's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Abelardo Silva Júnior

Universidade Federal de Viçosa

View shared research outputs
Top Co-Authors

Avatar

Gustavo Costa Bressan

Universidade Federal de Viçosa

View shared research outputs
Top Co-Authors

Avatar

Ieso de Miranda Castro

Universidade Federal de Ouro Preto

View shared research outputs
Top Co-Authors

Avatar

Luís Carlos Crocco Afonso

Universidade Federal de Ouro Preto

View shared research outputs
Top Co-Authors

Avatar

Maria Terezinha Bahia

Universidade Federal de Ouro Preto

View shared research outputs
Top Co-Authors

Avatar

Rogélio Lopes Brandão

Universidade Federal de Ouro Preto

View shared research outputs
Top Co-Authors

Avatar

Abelardo Silva-Júnior

Universidade Federal de Viçosa

View shared research outputs
Top Co-Authors

Avatar

Luciano Gomes Fietto

Universidade Federal de Ouro Preto

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge